AVP and autosomal dominant polycystic kidney disease: In this study, we examined the relative usefulness of serum copeptin levels as a surrogate marker of AVP by correlating it with baseline and longitudinal changes in markers of both renal function and common CVD manifestations (hypertensive vascular disease, atherosclerosis and endothelial dysfunction) that accompany the progression of ADPKD.